Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases

Author:

Milano Michael T1ORCID,Chiang Veronica L S2,Soltys Scott G3ORCID,Wang Tony J C4ORCID,Lo Simon S5,Brackett Alexandria6,Nagpal Seema7ORCID,Chao Samuel8,Garg Amit K9,Jabbari Siavash10,Halasz Lia M5,Gephart Melanie Hayden11,Knisely Jonathan P S12,Sahgal Arjun13,Chang Eric L14

Affiliation:

1. Department of Radiation Oncology, University of Rochester, Rochester, NY

2. Department of Neurosurgery, Yale School of Medicine, Yale University, New Haven, CT

3. Department of Radiation Oncology, Stanford University Medical Center, Stanford, CT

4. Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY

5. Department of Radiation Oncology, University of Washington, Seattle, WA

6. Cushing/Whitney Medical Library, Yale School of Medicine, Yale University, New Haven, CT

7. Department of Neurology, Stanford University School of Medicine, Stanford, CT

8. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

9. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Albuquerque, NM

10. Laurel Amtower Cancer Institute and Neuro-oncology Center, Sharp Healthcare, San Diego, CA

11. Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA

12. Department of Radiation Oncology, Weill Cornell Medicine, Cornell University, New York, NY

13. Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON

14. Department of Radiation Oncology, Keck School of Medicine of University of Southern California, Los Angeles, CA

Abstract

Abstract Background The American Radium Society (ARS) Appropriate Use Criteria brain malignancies panel systematically reviewed (PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses]) published literature on neurocognitive outcomes after stereotactic radiosurgery (SRS) for patients with multiple brain metastases (BM) to generate consensus guidelines. Methods The panel developed 4 key questions (KQs) to guide systematic review. From 11 614 original articles, 12 were selected. The panel developed model cases addressing KQs and potentially controversial scenarios not addressed in the systematic review (which might inform future ARS projects). Based upon quality of evidence, the panel confidentially voted on treatment options using a 9-point scale of appropriateness. Results The panel agreed that SRS alone is usually appropriate for those with good performance status and 2–10 asymptomatic BM, and usually not appropriate for >20 BM. For 11–15 and 16–20 BM there was (between 2 case variants) agreement that SRS alone may be appropriate or disagreement on the appropriateness of SRS alone. There was no scenario (among 6 case variants) in which conventional whole-brain radiotherapy (WBRT) was considered usually appropriate by most panelists. There were several areas of disagreement, including: hippocampal sparing WBRT for 2–4 asymptomatic BM; WBRT for resected BM amenable to SRS; fractionated versus single-fraction SRS for resected BM, larger targets, and/or brainstem metastases; optimal treatment (WBRT, hippocampal sparing WBRT, SRS alone to all or select lesions) for patients with progressive extracranial disease, poor performance status, and no systemic options. Conclusions For patients with 2–10 BM, SRS alone is an appropriate treatment option for well-selected patients with good performance status. Future study is needed for those scenarios in which there was disagreement among panelists.

Funder

The ARS

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3